From insight to infrastructure: Managing cardiorespiratory fitness.
Why cardiorespiratory fitness should be treated as a measurable and manageable health indicator-and why healthcare needs the infrastructure to act on it.
View publicationClinical Evidence
MHF is built on peer-reviewed research, real-world clinical implementation, patent-pending platform development, and a responsible pathway toward future regulated clinical decision support.
Peer-reviewed Publications
Plain-language summaries of published research from Dr. Alter and collaborators on cardiometabolic outcomes, structured exercise dose, and population health.
Why cardiorespiratory fitness should be treated as a measurable and manageable health indicator-and why healthcare needs the infrastructure to act on it.
View publicationReal-world implementation of an integrated digital program combining exercise, lifestyle education, disease-management support, and continuous patient engagement.
View publicationA systematic review showing that prolonged sedentary time is associated with mortality, cardiovascular disease, diabetes, cancer, and hospitalization-even after accounting for physical activity.
View publicationA population-level analysis examining whether Ontario's cardiovascular risk-reduction programs had enough capacity to serve the patients who could benefit.
View publicationPatent-pending Platform
MHF's platform is patent-pending across its exercise interpretation, projection logic, and reporting framework. The methodology has been refined over years of real-world clinical implementation and is grounded in published cardiometabolic outcomes literature.
Detailed methodology and conversion logic are protected and not publicly disclosed.
Real-world Implementation
MHF was refined through real-world implementation across clinical, community, employer, and research settings, including the operational learning that emerged from the Milton Cardiac Care program founded by Dr. Alter in 2010.
Setting 01
Integrated into a regional cardiology program serving 3,000+ cardiometabolic patients across community and hospital settings.
Setting 02
Implementation partnerships exploring engagement, activation, and projected value for organizational populations.
Setting 03
Collaborations supporting validation, reporting frameworks, and evidence generation.
Regulatory Pathway
MHF is currently operating as a cardiology-designed, educational, population-informed platform in an early implementation and evidence-generation phase. We are building toward regulated clinical decision-support pathways, including FDA and Health Canada SaMD validation.
MHF is not currently marketed as FDA-approved or Health Canada-approved clinical decision support. We are building the evidence, implementation experience, and regulatory strategy required for responsible future clinical use.
Collaborate With Us
We welcome conversations with research institutions, regulatory partners, and clinical groups interested in shaping the evidence base for responsible digital prevention.